Alamar Biosciences Inc

NAS:ALMRHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

$26.00−1.14%LiveIn session · ≈ AED 95.49 · Market cap $1.8B · Next earnings Tue 3 Nov

Ratio	FY2024	FY2025	Current · undated
Gross margin	34.2%	56.2%	—
Operating margin	−197.2%	−42.2%	−42.2%
Net margin	−187.2%	−40.2%	−40.2%
EBITDA margin	−184.4%	−33.5%	—
Return on equity	35.3%	18.8%	18.8%
Return on assets	−31.5%	−21.3%	−21.3%
Return on capital employed	−37.3%	−27.0%	—
Debt / equity	−2.0×	−0.3×	−0.3×
Debt / assets	179.3%	29.6%	—
Interest coverage	−23.9×	−78.1×	—
Current ratio	6.4×	4.0×	4.0×
Quick ratio	5.6×	2.4×	—
Cash ratio	1.6×	1.3×	1.3×
Asset turnover	0.2×	0.5×	—
Inventory turnover	1.1×	0.8×	—
Receivables turnover	3.6×	5.8×	—
Dividend payout	0.0%	0.0%	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.